Thilo Schroeder – Startup Investor Profile

Thilo Schroeder, Ph.D., is a Managing Partner at Nextech Invest with a passion for precision medicines in cancer. Thilo’s investment focus areas are oncology companies in Europe, the Middle East, and Africa. He specializes in investing in companies at the Clinical Trials – Phase 1 stage. Thilo’s geographical preference covers Asia, Europe, and North America. Known for his previous investments in companies like Revolution Medicines and PMV Pharmaceuticals, his professional career showcases a successful track record in the investment and healthcare sectors. Thilo invests in companies with a check size that aligns with the market norms. His partnership and collaboration styles involve engaging in dynamic social networks and collaborations for knowledge dissemination and new tool development.

Location:

Country: Switzerland

Investment Regions: EU, MENA

Investment Stages: pre-seed, seed

Website: https://www.nextechinvest.com/team/

AI Reasoning: SEC Form 4 for Revolution Medicines shows an acquisition (transaction date 12/05/2024) by Thilo Schroeder (via Nextech vehicles). The investment in Revolution Medicines occurred less than 6 months prior to the reference date, so tag is very-active. Startup invested: Revolution Medicines.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.